BRIEF published on 11/21/2024 at 07:05, 1 year 7 months ago Xlife Sciences AG Announces Upcoming Listing of FUSE-AI GmbH London Stock Exchange AI Technology Xlife Sciences AG Medical Innovation FUSE-AI GmbH
BRIEF published on 11/21/2024 at 07:05, 1 year 7 months ago Xlife Sciences AG annonce la prochaine cotation de FUSE-AI GmbH Innovation Médicale Xlife Sciences AG Bourse De Londres FUSE-AI GmbH Technologie De L'IA
PRESS RELEASE published on 11/21/2024 at 07:00, 1 year 7 months ago Xlife Sciences AG Announces the listing of FUSE-AI GmbH on the London Stock Exchange in the First Half of 2025 Xlife Sciences AG announces planned IPO of FUSE-AI GmbH on London Stock Exchange in first half of 2025, expanding into AI healthcare sector London Stock Exchange IPO Xlife Sciences AG AI Healthcare FUSE-AI GmbH
BRIEF published on 09/30/2024 at 20:05, 1 year 9 months ago Xlife Sciences AG Plans Dual Listing on London Stock Exchange London Stock Exchange Dual Listing Market Capitalization International Investors Stock Liquidity
BRIEF published on 09/30/2024 at 20:05, 1 year 9 months ago Xlife Sciences AG envisage une double cotation à la Bourse de Londres Investisseurs Internationaux Capitalisation Boursière Bourse De Londres Liquidité Des Stocks Double Cotation
PRESS RELEASE published on 09/30/2024 at 20:00, 1 year 9 months ago Xlife Sciences AG enables international co-investors to enter the stock and is planning a dual listing on the London Stock Exchange Group (LSEG) Xlife Sciences AG plans dual listing on London Stock Exchange Group to increase market capitalization and liquidity, benefiting shareholders Shareholders Dual Listing Market Capitalization Xlife Sciences AG London Stock Exchange Group
BRIEF published on 09/19/2024 at 07:05, 1 year 9 months ago Xlife Sciences AG: Successful First Half of 2024 with Strategic Progress and Solid Financial Figures Strategic Partnerships Financial Performance Life Sciences Xlife Sciences 2024 Half-Year Report
BRIEF published on 09/19/2024 at 07:05, 1 year 9 months ago Xlife Sciences AG : Premier semestre 2024 réussi avec des progrès stratégiques et des chiffres financiers solides Partenariats Stratégiques Performance Financière Sciences De La Vie Rapport Semestriel 2024 Sciences De La Vie X
PRESS RELEASE published on 09/19/2024 at 07:00, 1 year 9 months ago Xlife Sciences AG: Successful First Half of 2024 with Strategic Progress and Solid Financial Figures Xlife Sciences AG reports successful first half of 2024 with strategic progress and solid financial figures, including revenue growth and international partnerships Strategic Partnerships Revenue Growth Financial Report Business Development Xlife Sciences AG
BRIEF published on 09/03/2024 at 07:05, 1 year 10 months ago Xlife Sciences AG Completes Strategic Review Process by Q3 2024 Shareholders Portfolio Value Creation Strategic Review Implementation
Published on 07/08/2026 at 15:25, 6 hours 48 minutes ago Rockhaven Announces Granting of Incentive Stock Options
Published on 07/08/2026 at 15:00, 7 hours 13 minutes ago Karbon-X Announces Strategic Partnership to Evaluate Kenya BioHub Initiative
Published on 07/08/2026 at 15:00, 7 hours 13 minutes ago GameSquare's Stream Hatchet Publishes Esports Live Streaming Trends Report
Published on 07/08/2026 at 14:30, 7 hours 43 minutes ago Research Analyst Report on NanoViricides Rates Company "Outperform"; Separately, A "Fireside Chat" Interview of the Company's President Dr. Anil Diwan Hosted by Mr. Dave Donlin was Published by StockInvestor Daily
Published on 07/08/2026 at 21:00, 1 hour 13 minutes ago Legendary Entertainment and Warner Bros. Pictures Unveil Dune: Part Three Trailer and Behind-the-Scenes Images Showcasing Abu Dhabi as Arrakis
Published on 07/08/2026 at 19:42, 2 hours 31 minutes ago EQS-Adhoc: SMAG Mobile Antenna Masts AG sets final offer price for initial public offering (IPO) at EUR 46 per share
Published on 07/08/2026 at 18:52, 3 hours 20 minutes ago namR: PRONONCÉ DE LA LIQUIDATION JUDICIAIRE DE LA SOCIÉTÉ SA NAM.R
Published on 07/08/2026 at 18:45, 3 hours 28 minutes ago EQS-Adhoc: SCHOTT Pharma AG & Co. KGaA: SCHOTT Pharma publishes preliminary Q3 key figures and raises 2026 revenue and earnings guidance
Published on 07/08/2026 at 20:00, 2 hours 13 minutes ago ALTAREA - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 07/08/2026 at 20:00, 2 hours 13 minutes ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 07/08/2026 at 20:00, 2 hours 13 minutes ago ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES JUIN 2026
Published on 07/08/2026 at 20:00, 2 hours 13 minutes ago ALTAREA - DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES JUIN 2026
Published on 07/08/2026 at 20:00, 2 hours 13 minutes ago ALTAREIT : BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE
